Following a minor stroke, the road to recovery is often shaped by how quickly and effectively doctors can manage blood flow. A secondary analysis of a trial involving 995 Chinese patients looked at whether starting dual antiplatelet therapy (DAPT) early—combined with standard clot-busting medication—changed outcomes for those with diabetes.
The study found that patients who already had a history of diabetes saw a higher rate of excellent functional outcomes when they received early DAPT. Specifically, 91.2% of these patients achieved an excellent outcome compared to 81.7% in the group that did not receive it. However, this benefit was not seen in patients with newly diagnosed diabetes or those without diabetes at all.
While these results are promising for specific groups, experts note that this is a preliminary finding from a secondary analysis. Because the data comes from a specific population and requires further confirmation, it is not yet a definitive rule for all stroke patients. Patients should always discuss their specific treatment plan with their doctor.
